Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Aytu BioPharma, Inc. (AYTU)
USD2.23
+0.03 (+1.36%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address
373 Inverness Parkway 80112
Englewood, CO, US
Englewood, CO, US
CEO
Joshua R. Disbrow
Website
aytubio.com
IPO
2008-09-25
CIK 1385818 ISIN US0547548588
Description
Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international markets. Its commercialized portfolio includes several treatments for Attention Deficit Hyperactivity Disorder (ADHD): Adzenys XR-ODT, prescribed for patients aged 6 and up; Cotempla XR-ODT, tailored for individuals between 6 and 17 years old; and Adzenys ER, an oral liquid formulation also for those 6 years and older. Additionally, the company offers Karbinal ER, an oral carbinoxamine suspension for managing seasonal and perennial allergies. It also provides Poly-Vi-Flor and Tri-Vi-Flor, which are prescription vitamin supplements designed for infants and children with fluoride deficiencies. Other products include Tuzistra XR, a prescription cough suppressant oral suspension containing codeine polistirex and chlorpheniramine polistirex, and ZolpiMist, an oral spray indicated for addressing insomnia. Founded in 2015, the company was previously known as Aytu BioScience, Inc. before officially changing its name to Aytu BioPharma, Inc. in March 2021. Its corporate headquarters are located in Englewood, Colorado.
Market Cap & Enterprise Value
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.23
+0.03 (+1.36%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
38.6K
Beta
0.25
Float Shares
7.61M
Free Float %
93.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.74% | -10.85% | -9.80% | +5.50% | +11.65% | -11.54% | +85.48% | +25.00% | -97.83% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (5 ratings, all time)
Buy
Price Targets & DCF
Current price
2.23
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-3.79
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+1.8% Q1'26: -32.7% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+24.5% ★ Q1'26: -352.4% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-26.8% Q1'26: -33.7% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-15.1% Q1'26: +0.0% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%-91.7% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+13.4% Q1'26: +28.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-4.92× Q1'26: -0.11× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 2 Rev. Ana. 1 EPS Ana. |
Jun 2027 2 Rev. Ana. 1 EPS Ana. |
Jun 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.22M
est: 3.29M (-2.0%)
|
3.66M
est: 5.08M (-27.9%)
|
7.32M
est: 7.38M (-0.8%)
|
27.63M
est: 24.03M (+15.0%)
|
65.63M
est: 66.15M (-0.8%)
|
96.67M
est: 94.90M (+1.9%)
|
107.40M
est: 104.36M (+2.9%)
|
65.18M
est: 81.33M (-19.9%)
|
66.38M
est: 69.15M (-4.0%)
|
54.02M
53.64M – 54.72M
-21.9% YoY
|
70.63M
70.13M – 71.54M
+30.7% YoY
|
94.50M
93.83M – 95.72M
+33.8% YoY
|
| EBITDA |
-18.13M
est: -532.9K (-3,302.5%)
|
-15.25M
est: -16.48M (+7.5%)
|
-14.61M
est: -1.20M (-1,121.2%)
|
-12.21M
est: -3.90M (-213.3%)
|
-29.04M
est: -10.73M (-170.7%)
|
-27.96M
est: -15.39M (-81.7%)
|
-3.27M
est: -140.40M (+97.7%)
|
1.41M
est: -13.19M (+110.7%)
|
-4.67M
est: -11.21M (+58.4%)
|
-8.76M
-8.87M – -8.70M
+21.9% YoY
|
-11.45M
-11.60M – -11.37M
-30.7% YoY
|
-15.32M
-15.52M – -15.22M
-33.8% YoY
|
| EBIT |
-19.97M
est: -869.0K (-2,198.6%)
|
-17.84M
est: -22.64M (+21.2%)
|
-16.85M
est: -1.95M (-763.5%)
|
-17.92M
est: -6.35M (-182.1%)
|
-38.24M
est: -17.49M (-118.6%)
|
-38.10M
est: -25.10M (-51.8%)
|
-12.09M
est: -156.71M (+92.3%)
|
-5.32M
est: -21.51M (+75.3%)
|
-10.04M
est: -18.29M (+45.1%)
|
-14.29M
-14.47M – -14.19M
+21.9% YoY
|
-18.68M
-18.92M – -18.55M
-30.7% YoY
|
-24.99M
-25.31M – -24.81M
-33.8% YoY
|
| Net Income |
-22.51M
est: -1.20T (+100.0%)
|
-10.19M
est: -24.53M (+58.5%)
|
-47.17M
est: -2.70B (+98.3%)
|
-13.62M
est: -276.31M (+95.1%)
|
-58.29M
est: -356.69M (+83.7%)
|
-108.78M
est: -418.23M (+74.0%)
|
-17.05M
est: -17.05M (+0.0%)
|
-15.84M
est: -15.70M (-0.9%)
|
-13.56M
est: 2.12M (-739.0%)
|
-7.54M
-7.64M – -7.45M
-455.4% YoY
|
-2.37M
-2.41M – -2.34M
+68.5% YoY
|
1.95M
1.93M – 1.98M
+182.3% YoY
|
| SGA |
17.61M
est: 2.27M (+677.2%)
|
17.73M
est: 3.50M (+406.6%)
|
19.24M
est: 5.09M (+278.2%)
|
31.06M
est: 16.56M (+87.5%)
|
55.81M
est: 45.61M (+22.4%)
|
69.88M
est: 65.43M (+6.8%)
|
70.08M
est: 75.27M (-6.9%)
|
42.04M
est: 56.07M (-25.0%)
|
38.29M
est: 47.68M (-19.7%)
|
37.25M
36.99M – 37.73M
-21.9% YoY
|
48.70M
48.35M – 49.32M
+30.7% YoY
|
65.15M
64.69M – 65.99M
+33.8% YoY
|
| EPS |
-193,194.38
est: -190,400.00 (-1.5%)
|
-3,061.23
est: -17,160.00 (+82.2%)
|
-1,210.28
est: -430.00 (-181.5%)
|
-60.20
est: -44.00 (-36.8%)
|
-69.60
est: -56.80 (-22.5%)
|
-74.01
est: -66.60 (-11.1%)
|
-5.11
est: -6.16 (+17.0%)
|
-2.86
est: -2.49 (-14.9%)
|
-2.16
est: 0.34 (-741.6%)
|
-1.20
-1.22 – -1.19
-455.4% YoY
|
-0.38
-0.38 – -0.37
+68.5% YoY
|
0.31
0.31 – 0.32
+182.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-812.1K
OE per share TTM
-0.06
Owner's Yield
-3.52%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
5.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
5
Total invested
99.7K
Insider transactions (90d)
0
Beneficial owners (>5%)
39
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BARCLAYS GLOBAL INVESTORS, NA. | 9.15M | 4.68% | 5.05M | — | 5.05M | — | BK | Delaware, United States | 2016-05-19 | ↗ |
| 2 | Armistice Capital Master Fund Ltd. | 8.11M | 9.99% | — | 8.11M | — | 8.11M | CO | Delaware | 2017-08-24 | ↗ |
| 3 | Armistice Capital, LLC | 8.11M | 9.99% | — | 8.11M | — | 8.11M | IA, OO | Delaware | 2017-08-24 | ↗ |
| 4 | Steven Boyd | 8.11M | 9.99% | — | 8.11M | — | 8.11M | HC, IN | Delaware | 2017-08-24 | ↗ |
| 5 | James E. Besser | 5.56M | 6.10% | 1.36M | 4.21M | 1.36M | 4.21M | IN | Delaware | 2017-08-23 | ↗ |
| 6 | Altium Capital Management, LP | 5.00M | 9.90% | — | 5.00M | — | — | IA | Delaware, United States of America | 2019-10-21 | ↗ |
| 7 | Altium Growth Fund, LP | 5.00M | 9.90% | — | 5.00M | — | — | PN | Delaware, United States of America | 2019-10-21 | ↗ |
| 8 | Altium Growth GP, LLC | 5.00M | 9.90% | — | 5.00M | — | — | HC, OO | Delaware, United States of America | 2019-10-21 | ↗ |
| 9 | Manchester Management Company, LLC | 4.21M | 4.60% | — | 4.21M | — | 4.21M | OO | Delaware | 2017-08-23 | ↗ |
| 10 | Daniel B. Asher | 3.52M | 3.70% | — | 3.52M | — | 2.03M | HC, IN | United States of America | 2020-03-23 | ↗ |
| 11 | Intracoastal Capital LLC | 3.52M | 3.70% | — | 3.52M | — | 2.03M | OO | United States of America | 2020-03-23 | ↗ |
| 12 | Mitchell P. Kopin | 3.52M | 3.70% | — | 3.52M | — | 2.03M | HC, IN | United States of America | 2020-03-23 | ↗ |
| 13 | CVI Investments, Inc. | 3.40M | 5.60% | — | — | — | 3.40M | CO | Cayman Islands | 2022-08-15 | ↗ |
| 14 | Heights Capital Management, Inc. | 3.40M | 5.60% | — | — | — | 3.40M | CO | Cayman Islands | 2022-08-15 | ↗ |
| 15 | Empery Asset Management, LP | 3.11M | 9.38% | — | 3.11M | — | — | PN | Delaware | 2018-03-06 | ↗ |
| 16 | Martin D. Hoe | 3.11M | 9.38% | — | 3.11M | — | — | IN | Delaware | 2018-03-06 | ↗ |
| 17 | Ryan M. Lane | 3.11M | 9.38% | — | 3.11M | — | — | IN | Delaware | 2018-03-06 | ↗ |
| 18 | UBS Group AG directly and on behalf of certain subsidiaries | 2.00M | 16.14% | — | 2.00M | — | 2.00M | BK | Switzerland | 2019-03-08 | ↗ |
| 19 | 1992 MSF International Ltd. | 1.99M | 7.91% | — | 1.99M | — | — | OO | State of Delaware | 2018-03-12 | ↗ |
| 20 | Highbridge Capital Management, LLC | 1.99M | 7.91% | — | 1.99M | — | — | IA, OO | State of Delaware | 2018-03-12 | ↗ |
| 21 | Bigger Capital Fund GP, LLC | 1.61M | 7.40% | — | — | — | 1.61M | OO | Delaware | 2018-03-08 | ↗ |
| 22 | Bigger Capital Fund, LP | 1.61M | 7.40% | — | — | — | 1.61M | OO | Delaware | 2018-03-08 | ↗ |
| 23 | Michael Bigger | 1.61M | 7.40% | — | — | — | 1.61M | OO | Delaware | 2018-03-08 | ↗ |
| 24 | Hudson Bay Capital Management LP | 788.9K | 8.37% | — | 788.9K | — | — | PN | State of Delaware | 2019-02-01 | ↗ |
| 25 | Sander Gerber | 788.9K | 8.37% | — | 788.9K | — | — | IN | United States | 2019-02-01 | ↗ |
| 26 | Jon M. Plexico | 563.8K | 11.00% | — | 563.8K | — | — | HC, IN | Delaware | 2023-06-16 | ↗ |
| 27 | Stonepine Capital Management, LLC | 563.8K | 11.00% | — | 563.8K | — | — | IA, OO | Delaware | 2023-06-16 | ↗ |
| 28 | Stonepine Capital, L.P. | 563.8K | 11.00% | — | 563.8K | — | — | PN | Delaware | 2023-06-16 | ↗ |
| 29 | Timothy P. Lynch | 563.8K | 11.00% | — | 563.8K | — | — | HC, IN | Delaware | 2023-06-16 | ↗ |
| 30 | Daniel Mack | 271.6K | 7.20% | — | 271.6K | — | 271.6K | HC, IN | United States | 2023-05-26 | ↗ |
| 31 | Nantahala Capital Management, LLC | 271.6K | 7.20% | — | 271.6K | — | 271.6K | IA, OO | Massachusetts | 2023-05-26 | ↗ |
| 32 | Wilmot B. Harkey | 271.6K | 7.20% | — | 271.6K | — | 271.6K | HC, IN | United States | 2023-05-26 | ↗ |
| 33 | CVI Investments, Inc. | 232.7K | 9.90% | — | 232.7K | — | 232.7K | CO | Cayman Islands | 2018-10-12 | ↗ |
| 34 | Israel A. Englander | 22.9K | 0.10% | — | 22.9K | — | 22.9K | IN | — | 2021-03-26 | ↗ |
| 35 | Millennium Group Management LLC | 22.9K | 0.10% | — | 22.9K | — | 22.9K | OO | — | 2021-03-26 | ↗ |
| 36 | Millennium Management LLC | 22.9K | 0.10% | — | 22.9K | — | 22.9K | OO | — | 2021-03-26 | ↗ |
| 37 | Integrated Assets, Ltd. | 20.4K | 0.10% | — | 20.4K | — | 20.4K | CO | — | 2021-03-26 | ↗ |
| 38 | Millennium International Management LP | 20.4K | 0.10% | — | 20.4K | — | 20.4K | PN | — | 2021-03-26 | ↗ |
| 39 | Integrated Core Strategies (US) LLC | 2.4K | 0.00% | — | 2.4K | — | 2.4K | OO | — | 2021-03-26 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
5
-32 vs prev Q
New positions
0
Closed positions
32
Increased
0
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 10.0K +10.0K (+100.0%) | 26.00M +26.0M (+100.0%) | 0.10% +0.100 pp | 0.02% +0.020 pp | USD2.60 +0.0% | 1 qtrs NEW |
| 2 | NANTAHALA CAPITAL MANAGEMENT, LLC | 1.09M +— (+0.0%) | 2.83M +782.5K (+38.3%) | 10.83% -6.478 pp | 0.09% +0.023 pp | USD1.76 +47.7% | 12 qtrs — |
| 3 | STONEPINE CAPITAL MANAGEMENT, LLC | 813.7K -78.2K (-8.8%) | 2.12M +438.9K (+26.2%) | 8.11% -6.095 pp | 1.54% +0.182 pp | USD1.85 +40.5% | 11 qtrs — |
| 4 | AWM INVESTMENT COMPANY, INC. | 619.6K +— (+0.0%) | 1.61M +446.1K (+38.3%) | 6.17% -3.693 pp | 0.16% +0.046 pp | USD2.18 +19.3% | 3 qtrs — |
| 5 | DIADEMA PARTNERS LP | 305.8K +33.1K (+12.1%) | 795.0K +282.4K (+55.1%) | 3.05% -1.295 pp | 0.14% +0.006 pp | USD1.96 +32.7% | 2 qtrs — |
| 6 | VANGUARD GROUP INC | 278.6K +— (+0.0%) | 724.3K +200.6K (+38.3%) | 2.78% -1.661 pp | 0.00% +0.000 pp | USD1.97 +32.0% | 10 qtrs — |
| 7 | TWO SIGMA INVESTMENTS, LP | 107.1K +38.4K (+55.9%) | 278.5K +149.3K (+115.6%) | 1.07% -0.027 pp | 0.00% +0.000 pp | USD2.24 +16.1% | 3 qtrs — |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 89.6K -5.5K (-5.8%) | 233.0K +54.2K (+30.3%) | 0.89% -0.622 pp | 0.00% +0.000 pp | USD2.25 +15.6% | 12 qtrs — |
| 9 | PERSISTENT ASSET PARTNERS LTD | 79.4K +17.0K (+27.2%) | 206.5K +89.1K (+75.9%) | 0.79% -0.203 pp | 0.09% +0.012 pp | USD2.03 +28.1% | 2 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 74.1K +3.1K (+4.4%) | 192.7K +59.2K (+44.3%) | 0.74% -0.392 pp | 0.00% +0.000 pp | USD2.21 +17.6% | 12 qtrs — |
| 11 | TWO SIGMA ADVISERS, LP | 42.5K +2.7K (+6.8%) | 110.5K +35.7K (+47.7%) | 0.42% -0.210 pp | 0.00% +0.000 pp | USD1.93 +34.7% | 2 qtrs — |
| 12 | DIMENSIONAL FUND ADVISORS LP | 35.4K +4.4K (+14.2%) | 91.9K +33.7K (+57.9%) | 0.35% -0.141 pp | 0.00% +0.000 pp | USD1.97 +32.0% | 2 qtrs — |
| 13 | FNY INVESTMENT ADVISERS, LLC | 31.6K +31.6K (+100.0%) | 82.0K +82.0K (+100.0%) | 0.31% +0.315 pp | 0.02% +0.023 pp | USD2.60 +0.0% | 3 qtrs — |
| 14 | DRW SECURITIES, LLC | 29.4K +29.4K (+100.0%) | 76.4K +76.4K (+100.0%) | 0.29% +0.293 pp | 0.00% +0.002 pp | USD2.60 +0.0% | 1 qtrs NEW |
| 15 | XTX TOPCO LTD | 25.9K +25.9K (+100.0%) | 67.2K +67.2K (+100.0%) | 0.26% +0.258 pp | 0.00% +0.002 pp | USD2.60 +0.0% | 1 qtrs NEW |
| 16 | BELLEVUE ASSET MANAGEMENT, LLC | 25.0K +25.0K (+100.0%) | 65.0K +65.0K (+100.0%) | 0.25% +0.249 pp | 0.02% +0.021 pp | USD2.60 +0.0% | 1 qtrs NEW |
| 17 | BLACKROCK, INC. | 22.8K +— (+0.0%) | 59.3K +16.4K (+38.3%) | 0.23% -0.136 pp | 0.00% +0.000 pp | USD2.35 +10.6% | 6 qtrs — |
| 18 | SENTINUS, LLC | 20.0K +20.0K (+100.0%) | 52.0K +52.0K (+100.0%) | 0.20% +0.199 pp | 0.01% +0.005 pp | USD2.60 +0.0% | 1 qtrs NEW |
| 19 | PERRITT CAPITAL MANAGEMENT INC | 20.0K +20.0K (+100.0%) | 52.0K +52.0K (+100.0%) | 0.20% +0.199 pp | 0.09% +0.087 pp | USD2.60 +0.0% | 1 qtrs NEW |
| 20 | NORTHERN TRUST CORP | 19.2K +19.2K (+100.0%) | 49.8K +49.8K (+100.0%) | 0.19% +0.191 pp | 0.00% +0.000 pp | USD2.60 +0.0% | 1 qtrs NEW |
| 21 | CITADEL ADVISORS LLC | 15.6K +15.6K (+100.0%) | 40.4K +40.4K (+100.0%) | 0.15% +0.155 pp | 0.00% +0.000 pp | USD2.60 +0.0% | 1 qtrs NEW |
| 22 | ACADIAN ASSET MANAGEMENT LLC | 10.2K +— (+0.0%) | 26.0K +7.0K (+36.8%) | 0.10% -0.061 pp | 0.00% +0.000 pp | USD2.24 +16.1% | 12 qtrs — |
| 23 | MAI CAPITAL MANAGEMENT | 3.6K +— (+0.0%) | 9.3K +2.6K (+38.3%) | 0.04% -0.021 pp | 0.00% +0.000 pp | USD1.70 +52.9% | 5 qtrs — |
| 24 | UBS GROUP AG | 3.0K -86.0 (-2.7%) | 7.9K +2.0K (+34.5%) | 0.03% -0.020 pp | 0.00% +0.000 pp | USD2.15 +20.9% | 12 qtrs — |
| 25 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.7K -2.6K (-60.4%) | 4.5K -3.7K (-45.2%) | 0.02% -0.052 pp | 0.00% 0.000 pp | USD1.71 +52.0% | 12 qtrs — |
| 26 | ADVISOR GROUP HOLDINGS, INC. | 460.00 +5.0 (+1.1%) | 1.2K +393.0 (+48.9%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD2.12 +22.6% | 12 qtrs — |
| 27 | WELLS FARGO & COMPANY/MN | 127.00 +— (+0.0%) | 330.00 +91.0 (+38.1%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.24 +16.1% | 12 qtrs — |
| 28 | MORGAN STANLEY | 125.00 -161.0 (-56.3%) | 325.00 -213.0 (-39.6%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD2.54 +2.4% | 12 qtrs — |
| 29 | BANK OF AMERICA CORP /DE/ | 85.00 +11.0 (+14.9%) | 221.00 +82.0 (+59.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.64 -1.5% | 8 qtrs — |
| 30 | CIBC PRIVATE WEALTH GROUP, LLC | 83.00 +— (+0.0%) | 216.00 +60.0 (+38.5%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.99 -13.0% | 8 qtrs — |
| 31 | GROUP ONE TRADING, L.P. | 37.00 +— (+0.0%) | 96.00 +26.0 (+37.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.22 +17.1% | 12 qtrs — |
| 32 | BNP PARIBAS ARBITRAGE, SNC | 23.00 +— (+0.0%) | 60.00 +17.0 (+39.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.70 +52.9% | 5 qtrs — |
| 33 | NEWEDGE ADVISORS, LLC | 21.00 +— (+0.0%) | 55.00 +16.0 (+41.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.24 +16.1% | 12 qtrs — |
| 34 | SBI SECURITIES CO., LTD. | 11.00 -51.0 (-82.3%) | 29.00 -88.0 (-75.2%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.00 +30.0% | 5 qtrs — |
| 35 | VISION FINANCIAL MARKETS LLC | 2.00 +— (+0.0%) | 6.00 +2.0 (+50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +160.0% | 4 qtrs — |
| 36 | JONES FINANCIAL COMPANIES LLLP | 1.00 +— (+0.0%) | 3.00 +1.0 (+50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +160.0% | 4 qtrs — |
| 37 | CITIGROUP INC | 1.00 +— (+0.0%) | 3.00 +1.0 (+50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +160.0% | 2 qtrs — |
| 38 | BARCLAYS PLC | — -1.0 (-100.0%) | — -2.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 39 | FMR LLC | — -5.0 (-100.0%) | — -9.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 40 | JAFFETILCHIN INVESTMENT PARTNERS, LLC | — -17.4K (-100.0%) | — -32.8K (-100.0%) | 0.00% -0.278 pp | 0.00% -0.002 pp | USD— | 4 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 15 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - US Sustainability Core 1 ETF DFSU | 0.00% | 10.6K | 0.15% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 206.3K | 0.05% |
| 3 | Dimensional - US Core Equity 1 ETF DCOR | 0.00% | 4.7K | 0.14% |
| 4 | Dimensional - US Small Cap ETF DFAS | 0.00% | 9.7K | 0.26% |
| 5 | Dimensional - US Core Equity 2 ETF DFAC | 0.00% | 9.1K | 0.17% |
| 6 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 166.30 | 0.17% |
| 7 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 819.99 | 0.03% |
| 8 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 2.3K | 0.17% |
| 9 | Vanguard Total Stock Market ETF VTI | 0.00% | 384.8K | 0.03% |
| 10 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 842.90 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
3
Sells
0
Shares acquired
4.08M
Shares disposed
—
Cash buys
3.00
Cash sales
—
Net activity
+4,083,332
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-03 | Selhorn Ryan J | Officer | A-Award | A | Common Stock | 17,500 | 0.00 | — | 49,743 | D | ↗ |
| 2025-10-03 | PYSZCZYMUKA GREG | Officer | A-Award | A | Common Stock | 12,500 | 0.00 | — | 36,102 | D | ↗ |
| 2025-10-03 | LIU VIVIAN H | Director | A-Award | A | Common Stock | 10,000 | 0.00 | — | 19,825 | D | ↗ |
| 2025-10-03 | JAIN ABHINAV | Director | A-Award | A | Common Stock | 10,000 | 0.00 | — | 19,500 | D | ↗ |
| 2025-10-03 | Donofrio John Jr. | Director | A-Award | A | Common Stock | 10,000 | 0.00 | — | 13,762 | D | ↗ |
| 2025-10-03 | Disbrow Joshua R. | Director / Officer | A-Award | A | Common Stock | 22,500 | 0.00 | — | 207,203 | D | ↗ |
| 2025-10-03 | Disbrow Jarrett | Officer | A-Award | A | Common Stock | 12,500 | 0.00 | — | 61,568 | D | ↗ |
| 2025-10-03 | DOCKERY CARL | Director | A-Award | A | Common Stock | 10,000 | 0.00 | — | 20,440 | D | ↗ |
| 2025-06-30 | DOCKERY CARL | Director | — | — | Common Shares | 0 | 0.00 | — | 21,152 | D | ↗ |
| 2025-06-09 | Disbrow Joshua R. | Officer | P-Purchase | A | Common Stock | 66,666 | 1.50 | 100.0K | 153,257 | D | ↗ |
| 2025-06-09 | Disbrow Jarrett | Officer | P-Purchase | A | Common Stock | 16,666 | 1.50 | 25.0K | 29,462 | D | ↗ |
| 2025-06-06 | Nantahala Capital Management, LLC | 10% Owner | P-Purchase | A | Prefunded Warrants | 4,000,000 | 0.00 | 400.00 | 4,815,217 | I | ↗ |
| 2025-03-31 | PYSZCZYMUKA GREG | Officer | M-Exempt | A | Common Shares | 209 | 0.00 | — | 23,602 | D | ↗ |
| 2025-02-28 | Disbrow Joshua R. | Officer | P-Purchase | A | Common Stock | 15,000 | 1.30 | 19.5K | 86,591 | D | ↗ |
| 2025-02-05 | Selhorn Ryan J | Officer | M-Exempt | D | Restricted Stock Units | 105 | 0.00 | — | 0 | D | ↗ |
| 2024-12-31 | PYSZCZYMUKA GREG | Officer | M-Exempt | A | Common Shares | 208 | 0.00 | — | 23,393 | D | ↗ |
| 2024-11-11 | Selhorn Ryan J | Officer | A-Award | A | Common Shares | 14,000 | 0.00 | — | 15,895 | D | ↗ |
| 2024-11-06 | PYSZCZYMUKA GREG | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 7,000 | 1.84 | 12.9K | 7,000 | D | ↗ |
| 2024-11-06 | LIU VIVIAN H | Director | A-Award | A | Common Shares | 1,500 | 0.00 | — | 9,825 | D | ↗ |
| 2024-11-06 | JAIN ABHINAV | Director | A-Award | A | Common Shares | 1,500 | 0.00 | — | 9,500 | D | ↗ |
| 2024-11-06 | Donofrio John Jr. | Director | A-Award | A | Common Shares | 1,500 | 0.00 | — | 3,762 | D | ↗ |
| 2024-11-06 | Disbrow Joshua R. | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 38,000 | 1.84 | 69.9K | 38,000 | D | ↗ |
| 2024-11-06 | Disbrow Jarrett | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 7,000 | 1.84 | 12.9K | 7,000 | D | ↗ |
| 2024-11-06 | DOCKERY CARL | Director | A-Award | A | Common Shares | 1,500 | 0.00 | — | 10,440 | D | ↗ |
| 2024-09-30 | PYSZCZYMUKA GREG | Officer | M-Exempt | A | Common Shares | 209 | 0.00 | — | 23,185 | D | ↗ |
| 2024-06-30 | PYSZCZYMUKA GREG | Officer | M-Exempt | A | Common Shares | 208 | 0.00 | — | 22,976 | — | ↗ |
| 2024-06-14 | Nantahala Capital Management, LLC | 10% Owner | X-InTheMoney | A | Exchange Warrants | 815,217 | 0.00 | 81.52 | 815,217 | — | ↗ |
| 2024-03-31 | PYSZCZYMUKA GREG | Officer | M-Exempt | A | Common Shares | 208 | 0.00 | — | 22,768 | — | ↗ |
| 2023-12-31 | PYSZCZYMUKA GREG | Officer | M-Exempt | A | Common Shares | 209 | 0.00 | — | 22,560 | — | ↗ |
| 2023-09-30 | PYSZCZYMUKA GREG | Officer | M-Exempt | A | Common Shares | 208 | 0.00 | — | 22,351 | — | ↗ |
| 2023-08-16 | JAIN ABHINAV | Director | A-Award | A | Common Shares | 6,500 | 0.00 | — | 8,000 | — | ↗ |
| 2023-08-11 | PYSZCZYMUKA GREG | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 7,000 | 1.73 | 12.1K | 7,000 | — | ↗ |
| 2023-08-11 | Oki Mark K | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 13,000 | 1.73 | 22.5K | 13,000 | — | ↗ |
| 2023-08-11 | LIU VIVIAN H | Director | A-Award | A | Common Shares | 1,500 | 0.00 | — | 8,325 | D | ↗ |
| 2023-08-11 | JAIN ABHINAV | Director | A-Award | A | Common Shares | 1,500 | 0.00 | — | 1,500 | — | ↗ |
| 2023-08-11 | Donofrio John Jr. | Director | A-Award | A | Common Shares | 1,500 | 0.00 | — | 2,262 | — | ↗ |
| 2023-08-11 | Disbrow Joshua R. | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 35,000 | 1.73 | 60.6K | 35,000 | — | ↗ |
| 2023-08-11 | Disbrow Jarrett | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 7,000 | 1.73 | 12.1K | 7,000 | — | ↗ |
| 2023-08-11 | DOCKERY CARL | Director | A-Award | A | Common Shares | 1,500 | 0.00 | — | 8,940 | — | ↗ |
| 2023-08-11 | BROOKE CHRISTOPHER | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 7,000 | 1.73 | 12.1K | 7,000 | — | ↗ |
| 2023-06-30 | PYSZCZYMUKA GREG | Officer | M-Exempt | A | Common Shares | 208 | 0.00 | — | 22,143 | — | ↗ |
| 2023-06-16 | PYSZCZYMUKA GREG | Officer | P-Purchase | A | Common Shares | 12,000 | 1.87 | 22.4K | 21,935 | — | ↗ |
| 2023-06-14 | Disbrow Joshua R. | Director / Officer | P-Purchase | A | Common Shares | 14,000 | 1.86 | 26.1K | 71,591 | — | ↗ |
| 2023-06-13 | Nantahala Capital Management, LLC | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,086,812 | — | ↗ |
| 2023-06-13 | JAIN ABHINAV | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-04-25 | PYSZCZYMUKA GREG | Officer | M-Exempt | A | Common Shares | 833 | 0.00 | — | 9,935 | — | ↗ |
| 2023-02-08 | LIU VIVIAN H | Director | A-Award | A | Common Shares | 6,500 | 0.00 | — | 6,825 | — | ↗ |
| 2022-12-21 | Donofrio John Jr. | Director | D-Return | D | Common Stock | 187,804 | 0.00 | — | 15,267 | — | ↗ |
| 2022-12-21 | DOCKERY CARL | Director | D-Return | D | Common Stock | 40,000 | 0.00 | — | 148,805 | — | ↗ |
| 2022-12-21 | Cantrell Gary | Director | D-Return | D | Common Stock | 40,000 | 0.00 | — | 164,089 | — | ↗ |
| 2022-12-20 | Disbrow Joshua R. | Officer | D-Return | D | Common Stock | 80,000 | 0.00 | — | 1,151,877 | — | ↗ |
| 2022-12-19 | PYSZCZYMUKA GREG | Officer | P-Purchase | A | Common Stock | 100,000 | 0.24 | 24.5K | 182,056 | — | ↗ |
| 2022-12-19 | Disbrow Joshua R. | Officer | P-Purchase | A | Common Stock | 112,371 | 0.22 | 25.0K | 1,231,877 | — | ↗ |
| 2022-11-18 | Oki Mark K | Director / Officer | A-Award | A | Common Shares | 90,000 | 0.23 | 20.7K | 190,000 | — | ↗ |
| 2022-11-18 | Disbrow Joshua R. | Director / Officer | A-Award | A | Common Shares | 222,000 | 0.24 | 52.6K | 1,119,506 | — | ↗ |
| 2022-11-15 | PYSZCZYMUKA GREG | Officer | — | D | Restricted Stock Units | 50,000 | 0.00 | — | — | — | ↗ |
| 2022-11-15 | Disbrow Jarrett | Officer | — | D | Employee Stock Option (Right to Buy) | 15 | 3,280.00 | 49.2K | — | — | ↗ |
| 2022-11-15 | BROOKE CHRISTOPHER | Officer | — | D | Employee Stock Option (Right to Buy) | 135,000 | 0.20 | 27.0K | — | — | ↗ |
| 2022-07-01 | LIU VIVIAN H | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-01-17 | Oki Mark K | Officer | A-Award | A | Common Shares | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2021-04-16 | MACALUSO MICHAEL | Director | A-Award | A | Common Stock | 187,804 | 0.00 | — | 208,079 | — | ↗ |
| 2021-04-16 | Donofrio John Jr. | Director | A-Award | A | Common Stock | 187,804 | 0.00 | — | 203,071 | — | ↗ |
| 2021-04-16 | Disbrow Joshua R. | Director / Officer | A-Award | A | Common Stock | 800,000 | 0.00 | — | 897,506 | — | ↗ |
| 2021-04-16 | DOCKERY CARL | Director | A-Award | A | Common Stock | 187,804 | 0.00 | — | 188,805 | — | ↗ |
| 2021-04-16 | Cantrell Gary | Director | A-Award | A | Common Stock | 187,804 | 0.00 | — | 204,089 | — | ↗ |
| 2021-04-08 | McLaughlin Gerald W. | Director | A-Award | A | Common Stock | 6,500 | 0.00 | — | 31,401 | — | ↗ |
| 2021-04-08 | Hecht Beth | Director | A-Award | A | Common Stock | 6,500 | 0.00 | — | 9,052 | — | ↗ |
| 2021-03-31 | Eisenstadt Richard I | Officer | A-Award | A | Common Shares | 55,000 | 0.00 | — | 68,734 | — | ↗ |
| 2021-03-29 | ARMISTICE CAPITAL, LLC | Director | J-Other | A | Common Stock | 0 | 0.00 | — | 1,342,378 | — | ↗ |
| 2021-03-20 | ARMISTICE CAPITAL, LLC | Director | J-Other | A | Common Stock | 0 | 0.00 | — | 1,340,293 | — | ↗ |
| 2021-03-19 | McLaughlin Gerald W. | Director | — | D | Common Stock, par value $0.0001 | 0 | 0.00 | — | 24,901 | — | ↗ |
| 2021-03-19 | Hecht Beth | Director | — | D | Common Stock, par value $0.0001 | 0 | 0.00 | — | 2,552 | — | ↗ |
| 2020-12-11 | ARMISTICE CAPITAL, LLC | Director | P-Purchase | A | Common Stock | 1,333,334 | 6.00 | 8.00M | 1,333,334 | — | ↗ |
| 2020-07-01 | Cerecor Inc. | 10% Owner | — | D | Convertible Preferred Stock | 9,805,845 | 0.00 | — | 0 | — | ↗ |
| 2020-06-08 | Mehta Ketan Bhupatrai | — | A-Award | A | Employee Stock Option Grant | 40,000 | 1.45 | 58.0K | 40,000 | — | ↗ |
| 2020-06-08 | MACALUSO MICHAEL | — | A-Award | A | Employee Stock Option Grant | 40,000 | 1.45 | 58.0K | 40,105 | — | ↗ |
| 2020-06-08 | Green David A | — | A-Award | A | Common Stock | 250,000 | 0.00 | — | 521,250 | — | ↗ |
| 2020-06-08 | Donofrio John Jr. | — | A-Award | A | Employee Stock Option Grant | 40,000 | 1.45 | 58.0K | 40,038 | — | ↗ |
| 2020-06-08 | Disbrow Joshua R. | — | A-Award | A | Employee Stock Option Grant | 100,000 | 1.45 | 145.0K | 100,275 | — | ↗ |
| 2020-06-08 | DOCKERY CARL | — | A-Award | A | Employee Stock Option Grant | 40,000 | 1.45 | 58.0K | 40,038 | — | ↗ |
| 2020-06-08 | Cantrell Gary | — | A-Award | A | Employee Stock Option Grant | 20,000 | 1.45 | 29.0K | 20,038 | — | ↗ |
| 2020-04-27 | ARMISTICE CAPITAL, LLC | Director | S-Sale | D | Common Stock | 5,108,921 | 1.82 | 9.30M | 0 | — | ↗ |
| 2020-04-15 | Cerecor Inc. | 10% Owner | S-Sale | D | Common Stock | 92,777 | 1.55 | 144.1K | 9,713,068 | — | ↗ |
| 2020-04-10 | Cerecor Inc. | 10% Owner | C-Conversion | A | Common Stock | 9,805,845 | 0.00 | — | 9,805,845 | — | ↗ |
| 2020-04-06 | ARMISTICE CAPITAL, LLC | Director | J-Other | A | Common Stock | 0 | 0.00 | — | 108,921 | — | ↗ |
| 2020-03-10 | ARMISTICE CAPITAL, LLC | Director | M-Exempt | A | Common Stock | 0 | 1.00 | — | 10,203,867 | — | ↗ |
| 2020-02-14 | ARMISTICE CAPITAL, LLC | Director / 10% Owner | J-Other | A | Warrants | 0 | 15.75 | — | 85,191 | — | ↗ |
| 2020-01-21 | Mehta Ketan Bhupatrai | — | A-Award | A | Common stock | 10,000 | 0.00 | — | 75,000 | — | ↗ |
| 2019-12-20 | ARMISTICE CAPITAL, LLC | Director / 10% Owner | P-Purchase | A | Common Stock | 0 | 0.00 | — | 7,950,000 | — | ↗ |
| 2019-12-19 | Disbrow Joshua R. | — | P-Purchase | A | Common Stock | 5,000 | 0.89 | 4.5K | 525,048 | — | ↗ |
| 2019-12-19 | ARMISTICE CAPITAL, LLC | Director / 10% Owner | P-Purchase | A | Common Stock | 0 | 0.00 | — | 7,924,000 | — | ↗ |
| 2019-10-30 | ARMISTICE CAPITAL, LLC | Director / 10% Owner | C-Conversion | A | Common Stock | 0 | 0.00 | — | 7,871,212 | — | ↗ |
| 2019-10-11 | ARMISTICE CAPITAL, LLC | Director / 10% Owner | P-Purchase | A | Warrants | 0 | 1.25 | — | 5,000,000 | — | ↗ |
| 2019-04-18 | ARMISTICE CAPITAL, LLC | Director / 10% Owner | J-Other | A | Common Stock | 0 | 0.00 | — | 5,120,064 | — | ↗ |
| 2019-02-13 | Mehta Ketan Bhupatrai | — | A-Award | A | Common Stock | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2019-02-13 | Green David A | — | A-Award | A | Common Stock | 3,500 | 1.04 | 3.6K | 269,750 | — | ↗ |
| 2019-02-05 | ARMISTICE CAPITAL, LLC | 10% Owner | — | D | Common Stock, par value $.0001 | 0 | 0.00 | — | 2,000,000 | — | ↗ |
| 2018-12-21 | Green David A | Officer | S-Sale | D | Common Stock | 3,330 | 0.81 | 2.7K | 266,250 | — | ↗ |
| 2018-11-30 | Mehta Ketan Bhupatrai | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-11-26 | Disbrow Joshua R. | Director / Officer | P-Purchase | A | Warrants (right to buy) | 5,000 | 72.00 | 360.0K | 5,000 | — | ↗ |
| 2018-10-24 | MACALUSO MICHAEL | Director | A-Award | A | Common Stock | 200,000 | 0.00 | — | 202,738 | — | ↗ |
| 2018-10-24 | Green David A | Officer | A-Award | A | Common Stock | 262,500 | 0.00 | — | 269,580 | — | ↗ |
| 2018-10-24 | Donofrio John Jr. | Director | A-Award | A | Common Stock | 150,000 | 0.00 | — | 152,663 | — | ↗ |
| 2018-10-24 | Disbrow Joshua R. | Director / Officer | A-Award | A | Common Stock | 445,500 | 0.00 | — | 470,048 | — | ↗ |
| 2018-10-24 | Disbrow Jarrett | Officer | A-Award | A | Common Stock | 337,500 | 0.00 | — | 359,475 | — | ↗ |
| 2018-10-24 | DOCKERY CARL | Director | A-Award | A | Common Stock | 150,000 | 0.00 | — | 152,663 | — | ↗ |
| 2018-10-24 | Cantrell Gary | Director | A-Award | A | Common Stock | 150,000 | 0.00 | — | 152,840 | — | ↗ |
| 2018-03-06 | Green David A | Officer | P-Purchase | A | Warrants | 66,600 | 0.54 | 36.0K | 66,600 | — | ↗ |
| 2018-03-06 | Disbrow Joshua R. | Director / Officer | P-Purchase | A | Common Stock | 226,105 | 0.45 | 101.7K | 490,949 | — | ↗ |
| 2018-03-06 | Disbrow Jarrett | Officer | P-Purchase | A | Warrants | 226,105 | 0.54 | 122.1K | 226,105 | — | ↗ |
| 2018-01-02 | Green David A | Officer | A-Award | A | Common Stock | 75,000 | 0.00 | — | 75,000 | — | ↗ |
| 2017-12-18 | Green David A | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-11-07 | MACALUSO MICHAEL | Director | A-Award | A | Common Stock | 50,000 | 0.00 | — | 54,739 | — | ↗ |
| 2017-11-07 | Donofrio John Jr. | Director | A-Award | A | Common Stock | 50,000 | 0.00 | — | 53,250 | — | ↗ |
| 2017-11-07 | Disbrow Joshua R. | Director / Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 264,844 | — | ↗ |
| 2017-11-07 | Disbrow Jarrett | Director / Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 213,385 | — | ↗ |
| 2017-11-07 | DOCKERY CARL | Director | A-Award | A | Common Stock | 50,000 | 0.00 | — | 95,115 | — | ↗ |
| 2017-11-07 | Cantrell Gary | Director | A-Award | A | Common Stock | 50,000 | 0.00 | — | 56,771 | — | ↗ |
| 2017-08-15 | Disbrow Joshua R. | Director / Officer | A-Award | A | Common Stock | 1,666,667 | 0.15 | 250.0K | 2,296,861 | — | ↗ |
| 2017-08-15 | Disbrow Jarrett | Director / Officer | A-Award | A | Common Stock | 1,666,667 | 0.15 | 250.0K | 2,267,671 | — | ↗ |
| 2017-03-16 | MACALUSO MICHAEL | Director | A-Award | A | Stock Option Grant | 8,334 | 0.82 | 6.8K | 8,334 | — | ↗ |
| 2017-03-16 | Gould Gregory A | Officer | A-Award | A | Employee Stock Option Grant | 20,834 | 0.82 | 17.1K | 20,834 | — | ↗ |
| 2017-03-16 | Donofrio John Jr. | Director | D-Return | D | Employee Stock Option Grant | 15,000 | 3.23 | 48.5K | 0 | — | ↗ |
| 2017-03-16 | Disbrow Joshua R. | Director / Officer | A-Award | A | Employee Stock Option Grant | 60,000 | 0.82 | 49.2K | 60,000 | — | ↗ |
| 2017-03-16 | Disbrow Jarrett | Director / Officer | A-Award | A | Employee Stock Option Grant | 60,000 | 0.82 | 49.2K | 60,000 | — | ↗ |
| 2017-03-16 | DOCKERY CARL | Director | A-Award | A | Stock Option Grant | 8,334 | 0.82 | 6.8K | 8,334 | — | ↗ |
| 2017-03-16 | Cantrell Gary | Director | A-Award | A | Employee Stock Option Grant | 15,000 | 0.82 | 12.3K | 15,000 | — | ↗ |
| 2017-02-27 | Gould Gregory A | Officer | M-Exempt | D | Warrant to Purchase Common Stock | 66,666 | 1.86 | 124.0K | 0 | — | ↗ |
| 2017-02-27 | Disbrow Joshua R. | Director / Officer | M-Exempt | A | Common Stock | 187,500 | 0.75 | 140.6K | 630,194 | — | ↗ |
| 2017-02-27 | Disbrow Jarrett | Director / Officer | M-Exempt | D | Warrant to Purchase Common Stock | 20,834 | 6.00 | 125.0K | 0 | — | ↗ |
| 2017-02-27 | DOCKERY CARL | Director | M-Exempt | D | Warrant to Purchase Common Stock | 416,667 | 6.00 | 2.50M | 0 | — | ↗ |
| 2017-02-27 | Cantrell Gary | Director | M-Exempt | A | Warrant to Purchase Common Stock | 33,333 | 1.86 | 62.0K | 0 | — | ↗ |
| 2016-12-16 | Disbrow Joshua R. | Director / Officer | P-Purchase | A | Warrant to Purchase Common Stock | 28,924 | 6.00 | 173.5K | 28,924 | — | ↗ |
| 2016-11-02 | Gould Gregory A | Officer | P-Purchase | A | Warrant to Purchase Common Stock | 66,666 | 1.86 | 124.0K | 66,666 | — | ↗ |
| 2016-11-02 | Disbrow Joshua R. | Director / Officer | P-Purchase | A | Common Stock | 166,666 | 1.50 | 250.0K | 442,694 | — | ↗ |
| 2016-11-02 | Disbrow Jarrett | Director / Officer | P-Purchase | A | Warrant to Purchase Common Stock | 166,666 | 1.86 | 310.0K | 166,666 | — | ↗ |
| 2016-11-02 | Cantrell Gary | Director | P-Purchase | A | Common Stock | 33,333 | 1.50 | 50.0K | 98,333 | — | ↗ |
| 2016-08-02 | Gould Gregory A | Officer | A-Award | A | Common Stock | 41,899 | 0.00 | — | 206,899 | — | ↗ |
| 2016-08-02 | Disbrow Joshua R. | Officer | A-Award | A | Common Stock | 52,374 | 0.00 | — | 276,028 | — | ↗ |
| 2016-08-02 | Disbrow Jarrett | Officer | A-Award | A | Common Stock | 48,184 | 0.00 | — | 246,838 | — | ↗ |
| 2016-07-12 | Donofrio John Jr. | Director | A-Award | A | Common Stock | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2016-07-12 | Cantrell Gary | Director | A-Award | A | Common Stock | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2016-07-07 | McGrael Jonathan H | Officer | D-Return | D | Employee Stock Option Grant | 16,667 | 18.12 | 302.0K | 0 | — | ↗ |
| 2016-07-07 | MACALUSO MICHAEL | Director | A-Award | A | Stock Option Grant | 10,417 | 3.23 | 33.6K | 10,417 | — | ↗ |
| 2016-07-07 | Gould Gregory A | Officer | D-Return | D | Employee Stock Option Grant | 20,834 | 18.12 | 377.5K | 0 | — | ↗ |
| 2016-07-07 | Disbrow Joshua R. | Officer | A-Award | A | Common Stock | 190,000 | 0.00 | — | 223,654 | — | ↗ |
| 2016-07-07 | Disbrow Jarrett | Officer | A-Award | A | Common Stock | 165,000 | 0.00 | — | 198,654 | — | ↗ |
| 2016-07-07 | DOCKERY CARL | Director | A-Award | A | Stock Option Grant | 8,334 | 3.23 | 26.9K | 8,334 | — | ↗ |
| 2016-05-06 | Disbrow Joshua R. | Officer | P-Purchase | A | Common Stock | 250,000 | 0.40 | 100.0K | 403,846 | — | ↗ |
| 2016-05-06 | Disbrow Jarrett | Officer | P-Purchase | A | Common Stock | 250,000 | 0.40 | 100.0K | 403,846 | — | ↗ |
| 2016-05-06 | DOCKERY CARL | Director | P-Purchase | A | Warrant to Purchase Common Stock | 5,000,000 | 0.50 | 2.50M | 5,000,000 | — | ↗ |
| 2016-05-06 | Cantrell Gary | Director | — | D | Warrant to Purchase Common Stock | 45,000 | 0.50 | 22.5K | 0 | — | ↗ |
| 2016-04-11 | MACALUSO MICHAEL | Director | A-Award | A | Employee Stock Option Grant | 100,000 | 0.56 | 56.0K | 100,000 | — | ↗ |
| 2016-04-11 | DOCKERY CARL | Director | A-Award | A | Employee Stock Option Grant | 100,000 | 0.56 | 56.0K | 100,000 | — | ↗ |
| 2016-01-20 | Disbrow Joshua R. | Officer | P-Purchase | A | Common Stock | 153,846 | 0.65 | 100.0K | 153,846 | — | ↗ |
| 2016-01-20 | Disbrow Jarrett | Officer | P-Purchase | A | Common Stock | 153,846 | 0.65 | 100.0K | 153,846 | — | ↗ |
| 2015-12-01 | Ampio Pharmaceuticals, Inc. | 10% Owner | J-Other | D | Common Stock | 10,399,661 | 0.00 | — | 1,226,407 | — | ↗ |
| 2015-11-11 | McGrael Jonathan H | Officer | A-Award | A | Employee Stock Option Grant | 200,000 | 1.51 | 302.0K | 200,000 | — | ↗ |
| 2015-11-11 | MACALUSO MICHAEL | Director | A-Award | A | Employee Stock Option Grant | 125,000 | 1.51 | 188.8K | 125,000 | — | ↗ |
| 2015-11-11 | Gould Gregory A | Officer | A-Award | A | Employee Stock Option Grant | 250,000 | 1.51 | 377.5K | 250,000 | — | ↗ |
| 2015-11-11 | Disbrow Joshua R. | Officer | A-Award | A | Employee Stock Option Grant | 600,000 | 1.51 | 906.0K | 600,000 | — | ↗ |
| 2015-11-11 | Disbrow Jarrett | Officer | A-Award | A | Employee Stock Option Grant | 600,000 | 1.51 | 906.0K | 600,000 | — | ↗ |
| 2015-09-30 | McGrael Jonathan H | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-04-16 | MACALUSO MICHAEL | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-04-16 | Gould Gregory A | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-04-16 | Disbrow Joshua R. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-04-16 | Disbrow Jarrett | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-03-19 | WIEGAND JAMES B | Director / Officer / 10% Owner | — | D | Common Stock, no par value | 0 | 0.00 | — | 2,340,659 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-98.5K
Shares Outstanding
8.10M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Joshua R. Disbrow Chief Executive Officer since April 2015 | 590.0K | — | — | 46.1K | 247.8K | — | 883.9K | 5.22% | ↗ |
| 2 | 2025 | Jarrett T. Disbrow Chief Business Officer since November 2022 | 386.3K | — | — | 8.5K | 154.5K | — | 549.2K | 1.55% | ↗ |
| 3 | 2025 | Ryan J. Selhorn Chief Financial Officer, Corporate Secretary and Treasurer since November 2024 | 379.8K | — | 24.8K | 6.1K | 128.0K | — | 538.6K | 5.73% | ↗ |
| 4 | 2025 | Greg Pyszczymuka Chief Commercial Officer since January 2022 | 401.4K | — | — | 8.5K | 112.2K | — | 522.1K | 1.63% | ↗ |
| 5 | 2025 | Mark K. Oki Former Chief Financial Officer, Corporate Secretary and Treasurer | 238.4K | — | — | — | — | — | 238.4K | 0.00% | ↗ |
| 6 | 2024 | Joshua R. Disbrow Chief Executive Officer since April 2015 | 590.0K | — | — | 55.0K | 283.2K | — | 928.2K | 5.93% | ↗ |
| 7 | 2024 | Mark K. Oki Former Chief Financial Officer, Corporate Secretary and Treasurer | 427.5K | — | — | 20.4K | 136.8K | — | 584.7K | 3.50% | ↗ |
| 8 | 2024 | Jarrett T. Disbrow Chief Business Officer since November 2022 | 386.3K | — | — | 11.0K | 144.8K | — | 542.1K | 2.03% | ↗ |
| 9 | 2024 | Greg Pyszczymuka Chief Commercial Officer since January 2022 | 389.4K | — | — | 11.0K | 115.9K | — | 516.3K | 2.13% | ↗ |
| 10 | 2023 | Joshua R. Disbrow Chairman and Chief Executive Officer since December 2012 | 590.0K | 118.0K | — | — | — | — | 708.0K | 0.00% | ↗ |
| 11 | 2023 | Joshua R. Disbrow Chief Executive Officer since April 2015 | 590.0K | — | — | — | 118.0K | — | 708.0K | 0.00% | ↗ |
| 12 | 2023 | Greg Pyszczymuka Chief Commercial Officer since January 2022 | 375.0K | — | — | 15.0K | 150.0K | — | 540.0K | 2.79% | ↗ |
| 13 | 2023 | Mark K. Oki Former Chief Financial Officer, Corporate Secretary and Treasurer | 415.0K | — | — | — | 83.0K | 24.8K | 522.8K | 0.00% | ↗ |
| 14 | 2023 | Mark K. Oki Chief Financial Officer, Corporate Secretary and Treasurer since January 2022 | 415.0K | 83.0K | — | — | — | 24.8K | 522.8K | 0.00% | ↗ |
| 15 | 2023 | Jarrett T. Disbrow Chief Business Officer since November 2022 | 375.0K | — | — | 17.6K | 62.4K | — | 455.0K | 3.86% | ↗ |
| 16 | 2022 | Joshua R. Disbrow Chairman and Chief Executive Officer since December 2012 | 590.0K | — | — | — | — | — | 590.0K | 0.00% | ↗ |
| 17 | 2022 | Mark K. Oki Chief Financial Officer, Corporate Secretary and Treasurer since January 2022 | 183.6K | 50.0K | 135.0K | — | — | — | 368.6K | 36.63% | ↗ |
| 18 | 2022 | Mark K Oki Chief Financial Officer, Secretary and Treasurer since January 2022 | 167.6K | 50.0K | 135.0K | — | — | — | 352.6K | 38.29% | ↗ |
| 19 | 2022 | Richard Eisenstadt Former Chief Financial Officer, Secretary and Treasurer, resigned in December 2021 | 269.2K | 61.7K | — | — | — | — | 330.9K | 0.00% | ↗ |
| 20 | 2021 | Joshua R. Disbrow Chief Executive Officer since December 2012 | 545.0K | 462.2K | 5.19M | — | — | — | 6.20M | 83.75% | ↗ |
| 21 | 2021 | David A. Green Former Chief Financial Officer, Secretary and Treasurer | 345.2K | 430.5K | — | — | — | 500.0K | 1.28M | 0.00% | ↗ |
| 22 | 2021 | Richard Eisenstadt Former Chief Financial Officer, Secretary and Treasurer, resigned in December 2021 | 151.9K | 175.0K | 455.9K | — | — | — | 782.9K | 58.24% | ↗ |
| 23 | 2021 | Richard Eisenstadt Former Chief Financial Officer, Secretary and Treasurer since April 2021 | 151.9K | 175.0K | 455.9K | — | — | — | 782.9K | 58.24% | ↗ |
| 24 | 2020 | Joshua R. Disbrow Chief Executive Officer since December 2012 | 607.6K | 185.0K | 652.5K | 140.3K | — | — | 1.59M | 50.01% | ↗ |
| 25 | 2020 | David A. Green Former Chief Financial Officer, Secretary and Treasurer | 400.0K | 150.0K | 362.5K | 140.3K | — | — | 1.05M | 47.76% | ↗ |
| 26 | 2020 | David A. Green Former Chief Financial Officer, Secretary and Treasurer, | 400.0K | 150.0K | 362.5K | 140.3K | — | — | 1.05M | 47.76% | ↗ |
| 27 | 2019 | Joshua R. Disbrow Chief Executive Officer since December 2012 | 330.0K | 135.0K | 578.7K | — | — | — | 1.04M | 55.45% | ↗ |
| 28 | 2019 | Position Joshua R. Disbrow Chief Executive Officer since December 2012 | 330.0K | 135.0K | 578.7K | — | — | — | 1.04M | 55.45% | ↗ |
| 29 | 2019 | Jarrett T. Disbrow Chief Operating Officer since April 2015 | 250.0K | 105.0K | 438.4K | — | — | — | 793.4K | 55.26% | ↗ |
| 30 | 2019 | David A. Green Former Chief Financial Officer, Secretary and Treasurer, | 250.0K | 95.0K | 341.0K | — | — | — | 686.0K | 49.71% | ↗ |
| 31 | 2019 | David A. Green Chief Financial Officer, Secretary and Treasurer, since December 2017 | 250.0K | 95.0K | 341.0K | — | — | — | 686.0K | 49.71% | ↗ |
| 32 | 2018 | Joshua R. Disbrow Chief Executive Officer since December 2012 | 303.0K | — | 303.0K | — | — | — | 606.0K | 50.00% | ↗ |
| 33 | 2018 | Position Joshua R. Disbrow Chief Executive Officer since December 2012 | 303.0K | — | 303.0K | — | — | — | 606.0K | 50.00% | ↗ |
| 34 | 2018 | Jarrett T. Disbrow Chief Operating Officer, Secretary and Treasurer | 250.0K | — | 202.0K | — | — | — | 452.0K | 44.69% | ↗ |
| 35 | 2018 | Jarrett T. Disbrow Chief Operating Officer since April 2015 | 250.0K | — | 202.0K | — | — | — | 452.0K | 44.69% | ↗ |
| 36 | 2018 | David A. Green Chief Financial Officer since December 2017 | 135.0K | — | 152.0K | — | — | — | 287.0K | 52.96% | ↗ |
| 37 | 2018 | David A. Green Chief Financial Officer, Secretary and Treasurer, since December 2017 | 135.0K | — | 152.0K | — | — | — | 287.0K | 52.96% | ↗ |
| 38 | 2018 | Gregory A. Gould Chief Financial Officer | 96.0K | — | — | — | — | — | 96.0K | 0.00% | ↗ |
| 39 | 2017 | Joshua R. Disbrow ChiefExecutive Officer since December 2012 | 250.0K | — | 614.0K | 189.0K | — | — | 1.05M | 76.26% | ↗ |
| 40 | 2017 | Joshua R. Disbrow Chief Executive Officer since December 2012 | 250.0K | — | 614.0K | 189.0K | — | — | 1.05M | 76.26% | ↗ |
| 41 | 2017 | Jarrett T. Disbrow Chief Operating Officer, Secretary and Treasurer | 250.0K | — | 533.0K | 189.0K | — | — | 972.0K | 74.28% | ↗ |
| 42 | 2017 | Jonathan H. McGrael VP of Commercial Operations | 144.0K | 75.0K | 452.0K | 91.0K | — | 61.0K | 823.0K | 65.98% | ↗ |
| 43 | 2017 | Gregory A. Gould Chief Financial Officer since June 2014 | 10.0K | — | 533.0K | 79.0K | — | — | 622.0K | 98.39% | ↗ |
| 44 | 2017 | Gregory A. Gould Chief Financial Officer | 10.0K | — | 533.0K | 79.0K | — | — | 622.0K | 98.39% | ↗ |
| 45 | 2016 | Joshua R. Disbrow ChiefExecutive Officer since December 2012 | 250.0K | 313.0K | — | 559.0K | — | — | 1.12M | 49.82% | ↗ |
| 46 | 2016 | Joshua R. Disbrow Chief Executive Officer since December 2012 | 250.0K | 312.5K | — | 559.0K | — | — | 1.12M | 49.84% | ↗ |
| 47 | 2016 | Jarrett T. Disbrow Chief Operating Officer, Secretary and Treasurer | 250.0K | 288.0K | — | 559.0K | — | — | 1.10M | 50.96% | ↗ |
| 48 | 2016 | Jonathan H. McGrael VP of Commercial Operations | 140.0K | 238.0K | — | 186.0K | — | 13.0K | 577.0K | 32.24% | ↗ |
| 49 | 2016 | Gregory A. Gould Chief Financial Officer since June 2014 | — | 250.0K | — | — | — | — | 250.0K | 0.00% | ↗ |
| 50 | 2015 | Joshua R. Disbrow Chief Executive Officer since December 2012 | 246.0K | 202.5K | — | 198.0K | — | 7.0K | 653.5K | 30.30% | ↗ |
| 51 | 2015 | Jarrett T. Disbrow Chief Operating Officer, Secretary and Treasurer | 218.0K | 5.0K | — | — | — | — | 223.0K | 0.00% | ↗ |
| 52 | 2015 | Gregory A. Gould Chief Executive Officer, since June 2014 | — | — | — | 66.0K | — | — | 66.0K | 100.00% | ↗ |
| 53 | 2015 | Gregory A. Gould Chief Financial Officer since June 2014 | — | — | — | 66.0K | — | — | 66.0K | 100.00% | ↗ |
| 54 | 2014 | Chief Executive Officer since December 2012 | 245.0K | 180.0K | — | 197.9K | — | — | 622.9K | 31.77% | ↗ |
| 55 | 2014 | Joshua R. Disbrow Chief Executive Officer since December 2012 | 334.8K | 227.5K | — | — | — | — | 472.5K | 0.00% | ↗ |
| 56 | 2014 | Jarrett T. Disbrow Chief Operating Officer, Secretary and Treasurer | 140.0K | 5.0K | — | 223.0K | — | — | 368.0K | 60.60% | ↗ |
| 57 | 2014 | Chief Operating Officer, Secretary and Treasurer since November 2013 | 210.0K | 5.0K | — | — | — | — | 215.0K | 0.00% | ↗ |
| 58 | 2014 | Chief Financial Officer since June 2014 | — | — | — | 66.0K | — | — | 66.0K | 100.00% | ↗ |
| 59 | 2014 | Vaughan Cliff, M.D. Former Chief Medical Officer | — | — | — | 65.0K | — | — | 65.0K | 100.00% | ↗ |
| 60 | 2014 | Former Chief Medical Officer | — | — | — | 64.6K | — | — | 64.6K | 100.00% | ↗ |
| 61 | 2013 | Chief Executive Officer since December 2012 | 229.0K | 127.5K | — | 353.4K | — | — | 709.9K | 49.79% | ↗ |
| 62 | 2013 | Chief Operating Officer, Secretary and Treasurer since November 2013 | 8.8K | 5.0K | — | 222.6K | — | — | 236.3K | 94.18% | ↗ |
| 63 | 2013 | Chief Financial Officer since June 2014 | — | — | — | — | — | — | — | — | ↗ |
| 64 | 2012 | Chief Operating Officer, Secretary and Treasurer since November 2013 | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joshua R. Disbrow | Chief Executive Officer & Director | 837.8K | male |
| Jarrett T. Disbrow | Chief Business Officer | 540.8K | male |
| Greg Pyszczymuka | Chief Commercial Officer | 513.6K | male |
| Ryan J. Selhorn | Chief Financial Officer, Corporate Secretary & Treasurer | 507.8K | male |
| Gerwin Westfield | Senior Vice President of Scientific Affairs | — | — |
| Margaret Cabano | Vice President of Operations | — | female |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AYTU
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
